OPKO Health, Inc. (OPK)
NASDAQ: OPK · Real-Time Price · USD
1.340
-0.010 (-0.74%)
At close: Dec 5, 2025, 4:00 PM EST
1.330
-0.010 (-0.75%)
After-hours: Dec 5, 2025, 7:56 PM EST
OPKO Health Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for OPKO Health stock have an average target of 2.28, with a low estimate of 1.60 and a high estimate of 3.00. The average target predicts an increase of 70.15% from the current stock price of 1.34.
Analyst Consensus: Buy
* Price targets were last updated on Oct 31, 2025.
Analyst Ratings
The average analyst rating for OPKO Health stock from 5 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Nov 20, 2025 |
| Jefferies | Jefferies | Strong Buy → Hold Downgrades $2 → $1.6 | Strong Buy → Hold | Downgrades | $2 → $1.6 | +19.40% | Oct 31, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +67.91% | Oct 30, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $2.25 | Buy | Maintains | $2.25 | +67.91% | May 1, 2025 |
| JP Morgan | JP Morgan | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Apr 25, 2025 |
Financial Forecast
Revenue This Year
604.09M
from 713.14M
Decreased by -15.29%
Revenue Next Year
586.78M
from 604.09M
Decreased by -2.87%
EPS This Year
-0.33
from -0.08
EPS Next Year
-0.26
from -0.33
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 636.1M | 680.4M | ||||
| Avg | 604.1M | 586.8M | ||||
| Low | 583.1M | 524.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -10.8% | 12.6% | ||||
| Avg | -15.3% | -2.9% | ||||
| Low | -18.2% | -13.2% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.32 | -0.14 | |
| Avg | -0.33 | -0.26 | |
| Low | -0.34 | -0.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.